Therapeutics News

SAN FRANCISCO - A repeat trial of previously noncompliant dry eye subjects found an overall clinical benefit in 80% of patients after receiving education about the treatment medication, according to a poster presented here at Academy 2010.

SAN FRANCISCO - An ocular therapeutic agent caused no change in visual acuity, no decrease in wear time and no visible lens soiling when used with lotrafilcon A contact lenses, according to a poster presented here at Academy 2010.

SAN FRANCISCO - A retrospective case series of 10 contact lens intolerant women showed that the use of 5% transdermal testosterone lengthened their wearing time.

SAN FRANCISCO - A new class of drugs is being developed to fight bacteria, viruses and fungi, according to a presenter here at the Optometric Council on Refractive Technology meeting, held prior to the start of Academy 2010.

BEDFORD, Mass. — An antibiotic-containing punctum plug has moved one step closer to clinical trials after completion of a proof-of-principle study.

Five multivitamin supplements dissolved within 60 minutes in an environment simulated to resemble the human stomach, while three ocular multivitamins remained undissolved at 18 hours, a study found.

Nutraceuticals are pharmaceutical grade vitamins, minerals, essential fatty acids and antioxidants that may help correct the nutritional insufficiencies commonly found in our modern Western diet and environment. In turn, they may help prevent susceptibility to infection and chronic deficiencies and disease, according to researchers.

Power output during exercise affects cellular biology in many ways, some of which may lower the risk for eye disease, according to a practitioner.

Sustained glaucoma medication and constant IOP monitoring may help clinicians tailor treatment to the needs of individual patients, especially those who have difficulty adhering to treatment regimens and whose pressure varies over time.

The U.S. Food and Drug Administration assigns all drugs into one of five safety categories according to its “use-in-pregnancy rating system.” This system analyzes available human and animal clinical data and determines the degree of risk for teratogenic effects on the fetus.